{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:06:55Z","timestamp":1786550815441,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejca.2024.114312","type":"journal-article","created":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T06:21:46Z","timestamp":1728714106000},"page":"114312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prediabetes persistence or remission and subsequent risk of gallbladder cancer: A nationwide cohort study"],"prefix":"10.1016","volume":"213","author":[{"given":"Joo-Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Suk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Oh","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Yeong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay J.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2024.114312_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2024.114312_bib2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1186\/s12885-022-10286-z","article-title":"Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015","volume":"22","author":"Koshiol","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2024.114312_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2024.114312_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2024.114312_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cgh.2017.08.017","article-title":"Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers","volume":"16","author":"Torre","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2024.114312_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwaa199","article-title":"The chile biliary longitudinal study: a gallstone cohort","volume":"190","author":"Koshiol","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2024.114312_bib7","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/cncr.33476","article-title":"The global, regional, and national burden of gallbladder and biliary tract cancer and its attributable risk factors in 195 countries and territories, 1990 to 2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"127","author":"Ouyang","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2024.114312_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/dmrr.2671","article-title":"Type 2 diabetes mellitus and risk of gallbladder cancer: a systematic review and meta-analysis of observational studies","volume":"32","author":"Gu","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ejca.2024.114312_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0168-8278(98)80282-1","article-title":"Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans","volume":"28","author":"Gielkens","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2024.114312_bib10","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/0016-5085(88)90307-1","article-title":"Impairment of gallbladder emptying in diabetes mellitus","volume":"95","author":"Stone","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2024.114312_bib11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2024.114312_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","article-title":"The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer","volume":"18","author":"Sun","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2024.114312_bib13","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1053\/j.gastro.2011.02.055","article-title":"PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts","volume":"140","author":"He","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2024.114312_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(19)30064-6","article-title":"Definitions of intermediate hyperglycaemia and progression to type 2 diabetes","volume":"7","author":"Tuomilehto","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejca.2024.114312_bib15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jama.2023.4063","article-title":"Diagnosis and management of prediabetes: a review","volume":"329","author":"Echouffo-Tcheugui","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2024.114312_bib16","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc22-1321","article-title":"Natural history of prediabetes and long-term risk of clinical outcomes in middle-aged adults: the atherosclerosis risk in communities (ARIC) study","volume":"46","author":"Wallace","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejca.2024.114312_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejca.2024.114312_bib18","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2024.114312_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154848","article-title":"Association of prediabetes, diabetes, and diabetes duration with biliary tract cancer risk: a nationwide cohort study","volume":"123","author":"Park","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.ejca.2024.114312_bib20","unstructured":"Centers for Disease Control and Prevention: National Diabetes Statistics Report. \u3008https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html\u3009 [accessed 25 April 2023]."},{"key":"10.1016\/j.ejca.2024.114312_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4093\/dmj.2022.0106","article-title":"Diabetes fact sheet in Korea 2021","volume":"46","author":"Bae","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.ejca.2024.114312_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-8587(19)30058-0","article-title":"Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil","volume":"7","author":"Schmidt","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejca.2024.114312_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2021.03.024","article-title":"Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study","volume":"150","author":"Park","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.114312_bib24","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1200\/JCO.22.00145","article-title":"Light-to-moderate alcohol consumption increases the risk of biliary tract cancer in prediabetes and diabetes, but not in normoglycemic status: a nationwide cohort study","volume":"40","author":"Park","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114312_bib25","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.22.01740","article-title":"Increased risk of young-onset digestive tract cancers among young adults age 20-39 years with nonalcoholic fatty liver disease: a nationwide cohort study","volume":"41","author":"Park","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114312_bib26","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1200\/JCO.2007.12.9866","article-title":"Choice and interpretation of statistical tests used when competing risks are present","volume":"26","author":"Dignam","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2024.114312_bib27","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1002\/sim.7501","article-title":"Practical recommendations for reporting Fine-Gray model analyses for competing risk data","volume":"36","author":"Austin","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2024.114312_bib28","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2023080","article-title":"Increased risk of cancer and cancer-related mortality in middle-aged Korean women with prediabetes and diabetes: a population-based study","volume":"45","author":"Tran","year":"2023","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.ejca.2024.114312_bib29","first-page":"579","article-title":"Counter-regulatory role of bile acid activated receptors in immunity and inflammation","volume":"10","author":"Fiorucci","year":"2010","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.ejca.2024.114312_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2024.114312_bib31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.gastro.2023.03.227","article-title":"Gallstones, cholecystectomy, and kidney cancer: observational and mendelian randomization results based on large cohorts","volume":"165","author":"Kharazmi","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2024.114312_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","article-title":"FXR regulates intestinal cancer stem cell proliferation","volume":"176","author":"Fu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2024.114312_bib33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2023.02.022","article-title":"The gut microbial bile acid modulation and its relevance to digestive health and diseases","volume":"164","author":"Fogelson","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2024.114312_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fendo.2013.00071","article-title":"Adipokines mediate inflammation and insulin resistance","volume":"4","author":"Kwon","year":"2013","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ejca.2024.114312_bib35","first-page":"4","article-title":"Recent advances in the relationship between obesity, inflammation, and insulin resistance","volume":"17","author":"Bastard","year":"2006","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.ejca.2024.114312_bib36","first-page":"3963","article-title":"Association of IGFBP-6 expression with metabolic syndrome and adiponectin and igf-ir receptor levels in colorectal cancer","volume":"17","author":"Yunusova","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ejca.2024.114312_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091402","article-title":"Hyperglycemia associated metabolic and molecular alterations in cancer risk, progression, treatment, and mortality","volume":"11","author":"Ramteke","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2024.114312_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2024.114312_bib39","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2017.04.005","article-title":"Association of aflatoxin and gallbladder cancer","volume":"153","author":"Koshiol","year":"2017","journal-title":"Gastroenterology"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924009687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924009687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:33:17Z","timestamp":1733992397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924009687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":39,"alternative-id":["S0959804924009687"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114312","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediabetes persistence or remission and subsequent risk of gallbladder cancer: A nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114312"}}